Researchers from institutions across the U.S. and Canada collaborated on the statement, published Oct. 7 in JSCAI.
Here are five things to know:
- Experts agree reperfusion with primary percutaneous coronary intervention is associated with improved outcomes for patients with STEMI.
- The statement is not intended to replace current American College of Cardiology and American Heart Association guidelines.
- The statement offers recommendations and insights on the following:
- Cardiac catheterization lab equipment, team readiness and initial assessment
- Optimal techniques for angiography and intervention
- Managing thrombus
- Intracoronary imaging
- Emerging approaches to reduce infarct size
- Special circumstances, anatomical subsets and nonatherosclerotic causes of STEMI
- Experts recommend hospitals collect data on the treatment times and outcomes of patients with STEMI to identify and address areas of improvement.
- Researchers are currently investigating ways to streamline care and coordinate communication during treatment, as well as testing the use of AI to predict acute arterial occlusion.
Read the full statement here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
